Key facts
- Quodria’s last known valuation is $3.3M (Apr 2025).
- It has raised $320K; the latest was Seed Round ($320K) in Apr 2025.
- Notable investors include Deepbridge Capital, Alderley Park.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Quodria
- ·The full record, as it builds
Funding rounds
No funding rounds for Quodria are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Quodria
Operator of a skincare biotechnology firm intended to provide products for skin health. The company develops new skin therapies and over-the-counter products that have the potential to transform skincare, enabling dermatologists to focus on delivering a skincare system.
- Sector
- Healthcare
- HQ
- Cheshire, United Kingdom
- Founded
- 2024
- Employees
- 5
- Website
- quodria.com/
- Ownership
- Privately Held (backing)
Quodria doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Quodria shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Quodria in its N-PORT filings yet. We sweep new filings monthly.